JorsalAKistorpCHolmagerPTougaardRSNielsenRHnselmannAet alEffect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial
The perennial issue for all types of payers is money
Clinical trials and real-world evidence treat obesity as a chronic condition, much like high blood pressure or diabetes, which means it usually requires ongoing treatment rather than a short-term fix
The glucagon receptor activation in both compounds may help preserve muscle by promoting fat oxidation as the primary fuel source during caloric deficit
S-Acetyl glutathione has been found to increase intracellular glutathione and improve many biomarkers of oxidative stress
Without positive results from these two trials, the entire timeline shifts later